41 / 945
Treatment monitoring
wk1
wk2
wk3
DCE-MRI of
cervix cancer
during
external-beam
radiotherapy
wk1
wk2
wk3
6.50E-02
1.95E-01
3.25E-01
4.55E-01
5.85E-01
7.15E-01
8.45E-01
9.75E-01
1.11E+00
1.24E+00
1.37E+00
w k4
0
5
10
15
20
25
30
35
40
% of tumor volume
Ktrans
w k4
w k3
w k2
w k1
6.50E-02
1.95E-01
3.25E-01
4.55E-01
5.85E-01
7.15E-01
8.45E-01
9.75E-01
1.11E+00
1.24E+00
1.37E+00
w k4
0
5
10
15
20
25
30
35
40
% of tumor volume
Ktrans
w k4
w k3
w k2
w k1
6.50E-02
1.95E-01
3.25E-01
4.55E-01
5.85E-01
7.15E-01
8.45E-01
9.75E-01
1.11E+00
1.24E+00
1.37E+00
w k4
0
5
10
15
20
25
30
35
40
% of tumor volume
Ktrans